GeneDx
360Dx Top 30 Drops 9 Percent in February
Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.
Inclusive Newborn Sequencing Approach Shows Potential for Boosting Diagnostic Rate
Researchers increased the diagnostic rate for critically ill newborns by using simple, broad exclusion criteria rather than complicated guidelines for selecting infants to be sequenced.
The clinical genetic testing company's Q4 revenues jumped 64 percent year over year to $95.6 million, driven by its strong exome and whole-genome testing business.
GeneDx Shares Climb as Firm Kicks off Epic EHR Integration
After the integration, clinicians can order and send results on all of GeneDx's tests through Epic's Aura electronic health record software.
GeneDx Shares Fall on Short Seller Report
Several Wall Street analysts took issue with the short seller's report, calling the claims false and unrelated to GeneDx's current operations.